IRCT20231122060137N1招募中2 期
The effects of atorvastatin consumption on blood levels of sortilin, blood sugar and lipid indices in patients with type 2 diabetes
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 19 years 至 69 years（—）
- 性别
- All
入选标准
- •Type 2 diabetic patients have not used statin family drugs before treatment.
- •Healthy people should visit the laboratory for a routine checkup
- •Taking atorvastatin 40 mg/day for patients with type 2 diabetes who need treatment with this drug.
- •Diabetic patients have diabetes for at least 2 years.
- •Not received insulin in patients with type 2 diabetes and healthy people.
- •Use of hypoglycemic drugs in patients with type 2 diabetes
排除标准
- •Women who are pregnant or breastfeeding
- •People who have an active infection or hepatitis B, hepatitis C, HIV, or tuberculosis
- •History of any cancer
- •Heart attack in the last 6 months or peripheral coronary artery disease
- •Smoking and alcohol use
- •Women who use contraceptives
- •Indigestion and chronic diarrhea, failure of important organs, such as liver, lung, kidney, and brain, as well as anemia and diabetic nephropathy
研究者
相似试验
已完成
不适用
The effect of atorvastatin on biochemical and hemostatic profile of patients with polycystic ovary syndromeIRCT201208299626N1Tabriz University of Medical Sciences40
招募中
3 期
Atorvastatin in acute intracerebral hemorrhage.Intracerebral Hemorrhage.Nontraumatic intracerebral hemorrhage in hemisphere, unspecifiedI61.2IRCT20141116019971N6Shahid Beheshti University of Medical Sciences92
已完成
2 期
The effect of atorvastatin on patients with multiple sclerosisIRCT2015071323184N1Arak University of Medical Sciences60
招募中
3 期
The effect of atorvastatin administration on the outcome of patients with traumatic brain injuryIRCT20210113050023N1Ahvaz University of Medical Sciences60
已完成
不适用
Atorvastatin and endothelial function in systemic lupus erythematosus (SLE) patientsSystemic lupus erythematosus (SLE)Musculoskeletal DiseasesSystemic lupus erythematosusISRCTN19073445State of São Paulo Research Foundation (FAPESP) (Brazil)88